AstraZeneca
AZN
#52
Rank
S$348.81 B
Marketcap
S$224.91
Share price
-0.60%
Change (1 day)
-5.68%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): S$9.15

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is S$9.18. In 2024 the company made an earnings per share (EPS) of S$5.86 an increase over its 2023 EPS that were of S$4.95.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$9.15
2024S$5.8618.23%
2023S$4.9581.13%
2022S$2.73631.03%
2021S$0.37-88.11%
2020S$3.15136.89%
2019S$1.33-39.41%
2018S$2.19-28.27%
2017S$3.06-14.37%
2016S$3.5724.11%
2015S$2.88127.55%
2014S$1.26-51.96%
2013S$2.63-58.95%
2012S$6.41-32.2%
2011S$9.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.62-6.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$6.77-26.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$0.92-90.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$3.49-62.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.85 333.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$2.55-72.18%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$3.04-66.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$1.28-86.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$5.83-36.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$3.71-59.59%๐Ÿ‡ฌ๐Ÿ‡ง UK